Atos, Roselyn M.
HRN: 25-36-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2025
CEFTRIAXONE 1G (VIAL)
02/02/2025
02/09/2025
IV
2g
OD
For MRM
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes